Table 2.
Complication type | Prevalence (%) | Studies reported | Patients reported |
---|---|---|---|
Wound infection | 1.25 | 84 (55.3%) | 122,963 (24.3%) |
Urinary retention | 0.90 | 25 (16.4%) | 25,863 (5.1%) |
Bleeding | 0.79 | 86 (56.6%) | 146,712 (29%) |
Retained CBD stones | 0.50 | 45 (29.6%) | 111,674 (22.1%) |
Respiratory | 0.48 | 40 (26.3%) | 91,179 (18%) |
Cardiac | 0.36 | 32 (21.1%) | 50,862 (10.1%) |
Intraabdominal abscess | 0.34 | 38 (25%) | 60,517 (12%) |
Hernia | 0.21 | 33 (21.7%) | 58,849 (11.6%) |
Bowel injury | 0.15 | 44 (28.9%) | 99,102 (19.6%) |
Sepsis | 0.14 | 20 (13.2%) | 65,123 (12.9%) |
Pancreatitis | 0.14 | 18 (11.8%) | 39,453 (7.8%) |
DVT/PE | 0.13 | 14 (9.2%) | 18,070 (3.6%) |
Prolonged ileus | 0.04 | 17 (11.2%) | 54,150 (10.7%) |
CBD common bile duct, DVT/PE deep vein thrombosis/pulmonary embolus